A second “Biosimilar Week” is being rolled out in late May by Australia’s Generic and Biosimilar Medicines Association as part of education efforts underpinned by a three-year government grant.
Australian Initiative Aims To Educate On Biosimilars
Second ‘Biosimilar Awareness Week’ Launching In Late May
Australia’s GBMA is rolling out its second annual “Biosimilar Week” later this month as part of a three-year education program being pursued by the association and industry stakeholders.
More from Biosimilars
More from Products
• By
Organon has swelled its immunology biosimilar portfolio after acquiring the US commercial rights to Bio-Thera’s tocilizumab biosimilar from Biogen, which last year decided to retain its interests in biosimilars following a lengthy strategic review.
• By
The US FDA has deemed certain CRO Raptim Research’s in vitro bioequivalence studies as “not acceptable” and raised concerns over its in vivo study methods. Will other agencies follow suit?
• By
Teva should not be able to overturn European fines imposed over a historical “pay-for-delay” arrangement covering Cephalon’s Provigil (modafinil), an advocate general of the CJEU has recommended.